Torrent Pharma has a higher 5-year average ROCE of 15.37% compared to Sun pharma with 10.86%. The ROCE metric considers both Debt and Equity in relation to the net income earned by the company. The Return on Equity ratio shows the efficiency with which the company is able to generate profits. Sun Pharma has a lower ratio as compared to Torrent Pharma because the former has earned fewer profits. Sun Pharma Vs Torrent Pharma: Investor’s Earnings However, Torrent pharma has had a better margin than Sun Pharma in the last 3 years.
The net profit margin of both companies is low. Sun pharma has seen a fluctuation in its operating profit margin whereas Torrent Pharma has seen an improving margin in the last 3 years. The operating profit margin shows how much the company is making from its core business activities. On the other hand, Torrent Pharma has seen a rising trend in its gross profit margin in the last 3 years. The gross profit margin of Sun Pharma has been fluctuating over the last 5 years. Sun Pharma Vs Torrent Pharma: Profit Margins This was complemented by pandemic-led cost savings, productivity improvements, and operating leverage. It witnessed a significant improvement across operating and net earnings 11% and 22% Y-o-Y respectively. Torrent Pharmaceuticals earned a revenue of Rs 8,005 crores in 2020-21. 4% to ₹101 Billion which makes about 30% of their total consolidated revenues. However, revenues in the US business declined by approx. In FY21, Sun Pharma’s formulation sales stood at ₹103 Billion, up 6.5%, and accounted for about 31% of overall revenues. Adani Vs Ambani – The Battle For The Crown Of The Richest! Sun Pharma Vs Torrent Pharma: Revenue
0 kommentar(er)
